# OnCo record phage-delivery (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/phage-delivery/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "phage-delivery" ;
  schema:name "Bacteriophage-based tumour delivery"@en ;
  schema:description "Bacteriophage delivery uses viruses that infect bacteria, not human cells, as engineered shells whose coat proteins display tumour-homing peptides or antigens and carry drugs or vaccines. They are cheap and cannot replicate in people, but the work is preclinical: no oncology phage trial had reported efficacy by 2026, and the body clears them quickly."@en ;
  schema:url <https://onco.cc/technologies/phage-delivery/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?term=bacteriophage%20cancer> ;
  onco:status "preclinical" ;
  onco:tag "frontier", "radical" ;
  onco:sections <https://onco.cc/fronts/drug-discovery/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/oncolytic-virus/>, <https://onco.cc/technologies/shared-antigen-vaccine/> .